Literature DB >> 15107630

Re-evaluating selective screening criteria for chlamydial infection among women in the U S Pacific Northwest.

D Scott La Montagne1, L Elizabeth Patrick, David N Fine, Jeanne M Marrazzo.   

Abstract

OBJECTIVES: Screening women for Chlamydia trachomatis (CT) infection using selective screening criteria has been operational in the northwestern United States (Region X) since 1988. Changes in the field, including declines in CT prevalence, introduction of sensitive laboratory tests, and budgetary pressures necessitate reevaluating the selective screening approach to ensure program credibility and efficiency. GOALS: The goals of this study were to assess 1). performance of screening criteria in Region X, 2). predictors of CT infection, and 3). optimization of these criteria. STUDY
DESIGN: We conducted cross-sectional analysis of 409882 CT test records of women from 1998 to 2000 using multivariate logistic regression and sensitivity and efficiency analyses.
RESULTS: Young age (<25 yrs), cervical signs of infection, and recent exposure to or history of chlamydial infection were strongly associated with testing positive. Behavioral risks showed a weak association with infection. Currently used selective screening criteria were sensitive but not efficient. Criteria weighted toward young age, exposure to chlamydia, or cervicitis would increase criteria efficiency by nearly 25% in some settings while detecting >90% of infections.
CONCLUSION: Evaluating selective screening criteria can result in modifications that could increase screening efficiency.

Entities:  

Mesh:

Year:  2004        PMID: 15107630     DOI: 10.1097/01.olq.0000124613.85111.6b

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy.

Authors:  Arlene C Seña; Shelly Lensing; Anne Rompalo; Stephanie N Taylor; David H Martin; Laureen M Lopez; Jeannette Y Lee; Jane R Schwebke
Journal:  J Infect Dis       Date:  2012-05-21       Impact factor: 5.226

2.  Validation of a Clinical Prediction Rule to Predict Asymptomatic Chlamydia and Gonorrhea Infections Among Internet-Based Testers.

Authors:  Aidan Ablona; Titilola Falasinnu; Michael Irvine; Claudia Estcourt; Paul Flowers; Michelle Murti; Oralia Gómez-Ramírez; Christopher K Fairley; Sharmistha Mishra; Ann Burchell; Troy Grennan; Mark Gilbert
Journal:  Sex Transm Dis       Date:  2021-07-01       Impact factor: 2.830

3.  'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'.

Authors:  Jennifer Walker; Christopher K Fairley; Catriona S Bradshaw; Sepehr N Tabrizi; Marcus Y Chen; Jimmy Twin; Nicole Taylor; Basil Donovan; John K Kaldor; Kathleen McNamee; Eve Urban; Sandra Walker; Marian Currie; Hudson Birden; Francis Bowden; Jane Gunn; Marie Pirotta; Lyle Gurrin; Veerakathy Harindra; Suzanne Garland; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2011-02-01       Impact factor: 3.090

4.  Assessing the presence of Chlamydia trachomatis genome in pregnant women with spontaneous abortion using polymerase chain reaction method in Yasuj: First report from Southwest of Iran.

Authors:  Alborz Jahangiri Sisakht; Navid Omidifar; Nahid Mohamadkhani; Maryam Karimpoorfard; Mohammad Kargar; Mansoureh Shokripour
Journal:  J Educ Health Promot       Date:  2017-06-05

5.  Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study.

Authors:  Inger J Bakken; Sara Ghaderi
Journal:  BMC Infect Dis       Date:  2009-08-14       Impact factor: 3.090

6.  Risk prediction in sexual health contexts: protocol.

Authors:  Titilola Falasinnu; Paul Gustafson; Mark Gilbert; Jean Shoveller
Journal:  JMIR Res Protoc       Date:  2013-12-03

7.  Identifying youth at high risk for sexually transmitted infections in community-based settings using a risk prediction tool: a validation study.

Authors:  Katharina Kranzer; Victoria Simms; Ethel Dauya; Ioana D Olaru; Chido Dziva Chikwari; Kevin Martin; Nicol Redzo; Tsitsi Bandason; Mandikudza Tembo; Suzanna C Francis; Helen A Weiss; Richard J Hayes; Constancia Mavodza; Tsitsi Apollo; Gertrude Ncube; Anna Machiha; Rashida Abbas Ferrand
Journal:  BMC Infect Dis       Date:  2021-12-08       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.